|
|
|
Volumn , Issue 8, 2002, Pages 169-183
|
|
Stroke management.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
NEUROPROTECTIVE AGENT;
BRAIN HEMORRHAGE;
BRAIN INFARCTION;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
FIBRINOLYTIC THERAPY;
HUMAN;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK FACTOR;
SURVIVAL RATE;
ASPIRIN;
CEREBRAL HEMORRHAGE;
CEREBRAL INFARCTION;
CEREBROVASCULAR ACCIDENT;
COMBINED MODALITY THERAPY;
HUMANS;
NEUROPROTECTIVE AGENTS;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
SURVIVAL RATE;
THROMBOLYTIC THERAPY;
|
|
EID: 3042710783
PISSN: 14623846
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (54)
|
